-
August 09, 2012
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer's (PFE) ...
-
August 09, 2012
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer's (PFE) ...
-
August 02, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq has fallen 0.4%; the S&P 500 has declined ...
-
July 27, 2012
It's been a good morning for the market. The Nasdaq is up 1.4%; the S&P 500 has risen 1.1%; and the Dow has climbed ...
-
July 26, 2012
Gilead (Nasdaq:GILD) announced its results for the most recent quarter on July 26, 2012. Gilead Sciences is a ...
-
July 24, 2012
Celgene Corporation (CELG) is set to unveil its second quarter 2012 results on July 26, 2012 before the start of ...
-
July 23, 2012
The US Food and Drug Administration (FDA) recently approved Gilead Sciences, Inc.'s (GILD) once-daily oral Truvada ...
-
July 02, 2012
Recently, Gilead Sciences, Inc. (GILD) announced that it has filed a marketing application seeking approval for its ...
-
June 28, 2012
Recently, Gilead Sciences, Inc. (GILD) announced that it has filed a marketing application seeking approval for its ...
-
June 20, 2012
Recently, Gilead Sciences, Inc. (GILD) announced that its marketing application seeking approval for its HIV ...
-
June 05, 2012
As the world continues to modernize and grow, global cancer incidences are expected to increase exponentially and ...
-
June 02, 2012
While you never can be certain of what the future will bring, clearly Eli Lilly, Gilead Sciences, Biogen Idec all ...
-
March 21, 2012
Despite all of these uncertainties, investors still heavily focus on whether a company's new drug will be approved ...
-
February 21, 2012
The long-term appeal of Hanesbrands' business is still there, provided management delivers on its promise to reduce ...
-
February 19, 2012
Bullish magazine headlines have been the death of many a rising market, and in fact a correction is expected, says ...
-
February 15, 2012
Strong pipelines for the biotech sector as well as a wave of merger activity, have investors flocking to the stocks.
-
February 09, 2012
These three stocks have posted big gains this year, but a proven technical measure shows all are trading at levels ...
-
February 09, 2012
Following bullish earnings, Karee Venema of Schaeffer’s Research writes that call buyers are piling in to one ...
-
January 09, 2012
Bristol-Myers recently bought Inhibitex, a company leading the way in developing a treatment for Hepatitis C.
-
December 30, 2011
M&A activity rebounded in a big way in 2011. Here's a look back at the biggest mergers and acquisitions during the ...
